Trial Profile
Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Aug 2020
Price :
$35
*
At a glance
- Drugs Ioflupane 123I (Primary)
- Indications Alzheimer's disease; Dementia; Lewy body disease; Vascular dementia
- Focus Diagnostic use; Registrational
- Sponsors GE Healthcare
- 05 Jun 2014 New trial record